HMTXF

Hemostemix Inc

 
Common Stock
Grey Market
Contact Info
  • Suite 730
  • 1015 - 4th Street SW
  • Calgary, ALB T2R 1J4
  • Canada

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status International Reporting: Toronto Stock Exchange
Latest Report Sep 30, 2016 Interim Financial Report
Fiscal Year End 12/31
OTC Marketplace Grey Market
Profile Data
SIC - Industry Classification 8000 - Services-Health Services
Incorporated In: Canada
Year of Inc. 2014
Employees 12 a/o Oct 12, 2015
Company Officers/Contacts
Dr. Elmar Burchardt CEO
Angus Jenkins COO
David Berman CFO, IR
Dr. Ina Sarel VP, R&D
Dr. Hardean E. Achneck Other
Company Directors
Angus Jenkins Chairman
Lee Buckler
Robert L. Buckler
Dr. Elmar Burchardt
Victor H. Redekop
Service Providers
Accounting/Auditing Firm
MNP LLP
2701 Evans Avenue
8th Floor
Toronto, ONT, M9C 1A3
Canada
 
Securities Counsel
Heighenton Law Firm
1015 - 4 St SW, Suite 730
Calgary, ALB, T2R 1J4
Canada
 
Investor Relations Firm

Not Available
HMTXF Security Details
Share Structure
Market Value1 $27,496,110 a/o Mar 24, 2017
Authorized Shares Unlimited a/o Oct 05, 2015
Outstanding Shares 67,858,119 a/o Sep 20, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 65,802,119 a/o Oct 05, 2015
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Computershare Trust Company of Canada Inc.
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
HEM - Toronto Stock Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Mar 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security